Glenmark Pharmaceuticals has informed about Press Release dated June 15, 2015 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg’.
The above information is a part of company’s filings submitted to BSE.